98%
921
2 minutes
20
Introduction: There is no comprehensive data or studies relating to clinical presentation and prognosis of cerebral malaria (CM) in the tribal settlements of Assam. High rates of transmission and deaths from complicated malaria guided us to conduct a prospective observational cohort study to evaluate the factors associated with poor outcome and prognosis in patients of CM.
Materials And Methods: We admitted 112 patients to the Bandarpara and Damodarpur Tribal Health Centers (THCs) between 2011 and 2013 with a strict diagnosis of CM. We assessed the role of clinical, fundoscopy and laboratory findings (mainly lactic acid) in the immediate outcome in terms of death and recovery, duration of hospitalization, neurocognitive impairment, cranial nerve palsies and focal neurological deficit.
Results: The case fatality rate of CM was 33.03% and the prevalence of residual neurological sequelae at discharge was 16.07%. These are significantly higher than the previous studies. The mortality rate and neurological complications rate in patients with retinal whitening was 38.46% and 23.07%, with vessel changes was 25% and 18.75%, with retinal hemorrhage was 55.55% and 11.11% and with hyperlactatemia was 53.85% and 18.46%, respectively. Three patients of papilledema alone died.
Conclusion: Our study suggests a strong correlation between hyperlactatemia, retinal changes (whitening, vessel changes and hemorrhage) and depth and duration of coma with longer duration of hospitalization, increased mortality, neurological sequelae and death. Plasmodium vivax mono-infection as a cause of CM has been confirmed. Prognostic evaluation of CM is useful for judicious allocation of resources in the THC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879792 | PMC |
http://dx.doi.org/10.4103/0974-777X.177524 | DOI Listing |
J Int Med Res
September 2025
Department for Pathology, Chongqing General Hospital, China.
This case details a male patient in his late 50s weighing 90 kg who traveled to Burkina Faso, Africa, for approximately 1 month. He developed fever, headache, and generalized myalgia 3 days after returning to Chongqing, China. The interval from the emergence of the patient's symptoms to the diagnosis of severe falciparum malaria and the commencement of artesunate treatment was 9 days.
View Article and Find Full Text PDFCureus
August 2025
Infectious Diseases, Qazvin University of Medical Sciences, Qazvin, IRN.
Malaria is a potentially life-threatening parasitic disease caused by a protozoal infection via Plasmodium species, transmitted by a carrier female Anopheles mosquito. Cerebral malaria is typically caused by Plasmodium falciparum and is known as a fatal neurological complication of malaria. This systematic review and meta-analysis was performed due to limited research on the comparison of artemether and quinine for the treatment of cerebral malaria in children.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Cerebral malaria (CM), a life-threatening consequence of Plasmodium falciparum infection, is associated with a high fatality rate and long-term brain impairment in survivors. Despite advances in malaria treatment, effective therapies to mitigate the severe neurological consequences of CM remain limited. Consequently, novel antimalarial drugs with different mechanisms or neuroprotective advantages are urgently required.
View Article and Find Full Text PDFJ Neuroinflammation
August 2025
Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang City, Liaoning Province, 110122, P.R. China.
Cerebral malaria (CM) is the most severe complication of Plasmodium falciparum infection, and accounts for the majority of malaria-associated mortality. Reducing the overwhelming inflammatory responses in the early stage of infection is a key point to prevent death due to CM. In this study, we found that neutrophil mobilization occurred rapidly in response to Plasmodium berghei ANKA (PbA) infection in a murine CM model.
View Article and Find Full Text PDF